BioXcel Therapeutics, Inc. Inventory, Work in Process, Gross
BioXcel Therapeutics, Inc. (BTAI) had Inventory, Work in Process, Gross of $0 as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Current › Inventory, Net
us-gaap:InventoryWorkInProcess · last filed 2026-08-13
- 2026-06-30: Inventory, Work in Process, Gross $0.00.
- 2026-03-31: Inventory, Work in Process, Gross $0.00.
- 2025-12-31: Inventory, Work in Process, Gross $368.00K.
- 2025-09-30: Inventory, Work in Process, Gross $0.00.
| Period end | Inventory, Work in Process, Gross |
|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-13 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-15 |
| 2025-12-31 | $368.00K 10-Q · filed 2026-08-13 |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-12 |
| 2025-06-30 | $0.00 10-Q · filed 2025-08-12 |
| 2024-12-31 | $0.00 10-K · filed 2026-03-27 |
| 2024-06-30 | $387.00K 10-Q · filed 2024-08-06 |
| 2024-03-31 | $253.00K 10-Q · filed 2024-05-09 |
| 2023-12-31 | $651.00K 10-K · filed 2025-03-28 |
| 2023-09-30 | $605.00K 10-Q · filed 2023-11-14 |
| 2022-12-31 | $708.00K 10-K · filed 2024-03-22 |
| 2022-09-30 | $122.00K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $403.00K 10-Q · filed 2022-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |